| Financial Year |
March 31 2023 |
| Monetary Funds |
1,255,455,249.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,520,000.00 |
| Accounts Receivable |
973,173,685.02 |
| Advances to Suppliers |
81,860,018.98 |
| Other Receivables |
156,290,262.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
797,681,929.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,035,543.06 |
| Total Current Assets |
3,315,828,911.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,000,000.00 |
| Long-term Equity Investment |
20,490,623.51 |
| Investment Properties |
211,518,833.18 |
| Fixed Assetes |
5,259,802,301.96 |
| Under-construction Projects |
539,632,779.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
263,529,226.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,727,822.97 |
| Deferred Income Tax Assets |
105,916,303.01 |
| Other Non-Current Assets |
397,743,179.71 |
| Sub-Total of Non-Current Assets |
6,811,361,070.61 |
| Total Assets |
10,127,189,982.38 |
| Short-Term Loans |
3,776,842,542.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
250,051,054.29 |
| Accounts Payable |
557,311,958.01 |
| Accounts Received In Advance |
83,254,358.10 |
| Employee Compensation Payable |
40,679,767.37 |
| Taxes Payable |
25,752,778.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
340,494,755.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
249,851,662.45 |
| Other Current Liabilities |
149,312,096.16 |
| Sub-Total of Current Liabilities |
5,522,278,636.11 |
| Long-term Loans |
786,904,981.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
490,222,331.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
30,000,000.00 |
| Sub-Total of Non-Current Liabilities |
1,328,777,590.94 |
| Total Liabilities |
6,851,056,227.05 |
| Paid-In Capital(Or Share Stock) |
1,442,184,476.00 |
| Capital Surplus |
1,800,348,649.40 |
| Surplus Reserve |
240,064,319.15 |
| LESS:Treasury Stock |
204,000,000.00 |
| Undistributed Profits |
-2,509,813.87 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,276,133,755.33 |
| Owner's Equity（Stockholder's Equity） |
3,276,133,755.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,127,189,982.38 |
